152 related articles for article (PubMed ID: 3081993)
1. Double gammopathies: incidence and clinical course of 20 patients.
Nilsson T; Norberg B; Rudolphi O; Jacobsson L
Scand J Haematol; 1986 Jan; 36(1):103-6. PubMed ID: 3081993
[TBL] [Abstract][Full Text] [Related]
2. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.
Baldini L; Guffanti A; Cesana BM; Colombi M; Chiorboli O; Damilano I; Maiolo AT
Blood; 1996 Feb; 87(3):912-8. PubMed ID: 8562962
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal gammopathy in systemic lupus erythematosus.
Porcel JM; Ordi J; Tolosa C; Selva A; Castro-Salomo A; Vilardell M
Lupus; 1992 Aug; 1(4):263-4. PubMed ID: 1301990
[TBL] [Abstract][Full Text] [Related]
4. [Malignant transformation of monoclonal gammopathy of undetermined significance].
Decaux O; Avet-Loiseau H; Grosbois B
Presse Med; 2007 Dec; 36(12 Pt 3):1985-96. PubMed ID: 17509811
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal gammopathy in a tertiary referral hospital.
Tamimi W; Alaskar A; Alassiri M; Alsaeed W; Alarifi SA; Alenzi FQ; Jawdat D
Clin Biochem; 2010 Jun; 43(9):709-13. PubMed ID: 20206156
[TBL] [Abstract][Full Text] [Related]
6. [Acquired peripheral neuropathies associated with monoclonal gammopathy].
Gajos A; Kieliś W; Szadkowska I; Chmielowska E; Niewodniczy A; Bogucki A
Neurol Neurochir Pol; 2007; 41(2):169-75. PubMed ID: 17530580
[TBL] [Abstract][Full Text] [Related]
7. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal gammopathy of undetermined significance.
Kyle RA; Rajkumar SV
Clin Lymphoma Myeloma; 2005 Sep; 6(2):102-14. PubMed ID: 16231848
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong.
Lolin YI; Chow J; Wickham NW
Am J Clin Pathol; 1996 Oct; 106(4):449-56. PubMed ID: 8853031
[TBL] [Abstract][Full Text] [Related]
10. Biclonal gammopathy (IgG kappa and IgG lambda) in a patient with non-Hodgkin's lymphoma.
Guarner J; Austin GE; Nassar VH; Sarma PR; Boedecker E
Arch Pathol Lab Med; 1986 May; 110(5):445-8. PubMed ID: 3083801
[TBL] [Abstract][Full Text] [Related]
11. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients.
Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J
Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065
[TBL] [Abstract][Full Text] [Related]
12. [Incidence and type of monoclonal or biclonal gammopathies in scrub typhus].
Cho JH; Park DS
Korean J Lab Med; 2009 Apr; 29(2):116-21. PubMed ID: 19411777
[TBL] [Abstract][Full Text] [Related]
13. Biclonal IgM gammopathy in chronic lymphocytic leukemia.
Schaffner KF; Krause JR; Kelly RH
Arch Pathol Lab Med; 1988 Feb; 112(2):206-8. PubMed ID: 3122707
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal and biclonal immunoglobulin-producing disorders.
Osterborg A; Mellstedt H
Eur J Haematol Suppl; 1989; 51():11-8. PubMed ID: 2697582
[TBL] [Abstract][Full Text] [Related]
15. Coexistence of double gammopathy (IgM kappa and IgM lambda) in the serum of a single individual with chronic lymphocytic leukemia.
Schipper H; Orr KB; Bow EJ
Acta Haematol; 1983; 69(1):23-31. PubMed ID: 6401889
[No Abstract] [Full Text] [Related]
16. Triclonal gammopathy (IgA kappa, IgG kappa, and IgM kappa) in a patient with plasmacytoid lymphoma derived from a monoclonal origin.
Murata T; Fujita H; Harano H; Hukawa M; Kanamori H; Matsuzaki M; Mohri H; Kudoh J; Shimizu N; Okubo T
Am J Hematol; 1993 Feb; 42(2):212-6. PubMed ID: 7679880
[TBL] [Abstract][Full Text] [Related]
17. Generalized acquired cutis laxa associated with multiple myeloma with biphenotypic IgG-λ and IgA-κ gammopathy following treatment of a nodal plasmacytoma.
New HD; Callen JP
Arch Dermatol; 2011 Mar; 147(3):323-8. PubMed ID: 21422340
[TBL] [Abstract][Full Text] [Related]
18. [Epidemiology of monoclonal gammopathy in a general hospital and a university internal medicine department].
Decaux O; Rodon P; Ruelland A; Estepa L; Leblay R; Grosbois B
Rev Med Interne; 2007 Oct; 28(10):670-6. PubMed ID: 17566610
[TBL] [Abstract][Full Text] [Related]
19. [A series of 618 cases of monoclonal gammopathies of undetermined significance: predictive factors of disappearance of monoclonal component or evolution to malignant gammopathies].
González García ME; Fernández Alvarez C; Robles Marinas V; González Huerta AJ; Arias Miranda MI; González Rodríguez AP; García Casas J; de La Tassa JM; Fernández García J
Rev Clin Esp; 2008 Jun; 208(6):288-94. PubMed ID: 18620653
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathy of undetermined significance (MGUS)-31 year follow up of a community study.
Colls BM
Aust N Z J Med; 1999 Aug; 29(4):500-4. PubMed ID: 10868527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
